Katherine K. Matthews
Herston, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Journal: Nature communications
Published: May 31, 2024
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Journal: JCI insight
Published: October 15, 2020
Pretransplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: A Prospective Cohort Study.
Journal: The Journal of infectious diseases
Published: October 14, 2020
Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases.
Journal: Clinical & translational immunology
Published: September 09, 2020
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma.
Journal: NPJ precision oncology
Published: August 16, 2020
Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme.
Journal: The Journal of clinical investigation
Published: March 31, 2020
Impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy.
Journal: Clinical & translational immunology
Published: May 15, 2019
T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response.
Journal: The Journal of clinical investigation
Published: February 21, 2019
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function.
Journal: Nature communications
Published: November 23, 2018
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Journal: JCI insight
Published: September 11, 2018
VDJdb: a curated database of T-cell receptor sequences with known antigen specificity.
Journal: Nucleic acids research
Published: June 23, 2017
Last Updated: 09/26/2026